Skip To Main Content
Meghan Langley on Muck Rack

Meghan Langley

As seen in: The BMJ

Get in touch with Meghan

Contact Meghan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Meghan Langley’s Biography

Read Full Bio →

pharmacy link <a href="https://www.thepharmacyone-rx.com">visit there</a>

Articles

457 Engineered tumor-infiltrating lymphocytes (TIL) with co-regulated membrane-bound IL15 (mbIL15) and LIGHT (TNFSF14) generate significant antitumor efficacy in fibrotic tumor models | Journal for ImmunoTherapy of Cancer

|
By Benjamin Primack, Balázs Koscsó, Violet Young, Meghan Langley
| The BMJ Verified
Abstract Background Non-engineered TIL cell therapy requiring co-administration of high-dose IL2 has shown promising activity, but concerning safety, in melanoma.
Open in Who Shared Issue with article?

463 Antigen-responsive promoters coupled with cytoDRiVE® technology provide tight spatiotemporal regulation for tumor-infiltrating lymphocytes (TIL) expressing membrane-bound IL12 | Journal for ImmunoTherapy of Cancer

|
By Sean Smith, Seàn Smith, Seán Smith, Meghan Langley, Theresa Ross, Patricia Timpug
| The BMJ Verified
http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial.
Open in Who Shared View Duplicates (151) Issue with article?
See all 2 articles